UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resting energy expenditure in the obese: A cross-validation and comparison of prediction equations

Journal of the American Dietetic Association, 1993-09, Vol.93 (9), p.1031-1036

1993

Volltextzugriff (PDF)

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Journal of hepatology, 2021-10, Vol.75 (4), p.829-839

2021

Volltextzugriff (PDF)

Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea

BMC veterinary research, 2022-06, Vol.18 (1), p.1-245, Article 245

2022

Volltextzugriff (PDF)

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

Journal of hepatology, 2020-03, Vol.72 (3), p.431-440

2020

Volltextzugriff (PDF)

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2124-2134

2013

Volltextzugriff (PDF)

Adding a polyphenol-rich fiber bundle to food impacts the gastrointestinal microbiome and metabolome in dogs

Frontiers in veterinary science, 2023-01, Vol.9, p.1039032-1039032

2023

Volltextzugriff (PDF)

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

PloS one, 2013-11, Vol.8 (11), p.e80003

2013

Volltextzugriff (PDF)

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Clinical infectious diseases, 2020-10, Vol.71 (7), p.e115-e124

2020

Volltextzugriff (PDF)

Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection

AIDS (London), 2012-08, Vol.26 (13), p.1653-1661

2012

Volltextzugriff (PDF)

THU-390-Results of a birth cohort hepatitis C screening program in an academic emergency department in Canada

Journal of hepatology, 2019-04, Vol.70 (1), p.e326-e327

2019

Volltextzugriff (PDF)

THU-389-Assessment of hepatitis C screening strategies in different community settings in a Canadian metropolitan area

Journal of hepatology, 2019-04, Vol.70 (1), p.e326-e326

2019

Volltextzugriff (PDF)

Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario

Canadian liver journal, 2022-08, Vol.5 (3), p.362-371

2022

Volltextzugriff (PDF)

Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

Value in health, 2023-06, Vol.26 (6), p.883-892

2023

Volltextzugriff (PDF)

PS-178-Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir: the SMART-C study

Journal of hepatology, 2019-04, Vol.70 (1), p.e110-e110

2019

Volltextzugriff (PDF)

Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE)

Journal of cardiac failure, 2000-12, Vol.6 (4), p.369-380

Abraham, William T.

2000

Volltextzugriff (PDF)

Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection: e80003

PloS one, 2013-11, Vol.8 (11)

2013

Volltextzugriff (PDF)

Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children

American journal of nephrology, 1994, Vol.14 (3), p.169-172

1994

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resting energy expenditure in the obese: A cross-validation and comparison of prediction equations

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Adding a polyphenol-rich fiber bundle to food impacts the gastrointestinal microbiome and metabolome in dogs

Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection

THU-390-Results of a birth cohort hepatitis C screening program in an academic emergency department in Canada

THU-389-Assessment of hepatitis C screening strategies in different community settings in a Canadian metropolitan area

Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario

Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

PS-178-Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir: the SMART-C study

Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE)

Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection: e80003

Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children

Suchergebnisse filtern